Fundraising Fox
/People
Sign in

Catherine Pickering

Founder

Co-Founder & CEO at iOnctura

Geneva, Geneva, Switzerland

FoundediOnctura

Find your path to Catherine

128 people in our graph share verified history with Catherine — schools, employers, funds. One of them is your warm intro.

George SyrmalisunlockedCatherine: together at Antisoma PLC (2004–2005)
×11Catherine: together at iOnctura

About

Catherine Pickering is CEO and Co-Founder of iOnctura SA, a Swiss-Dutch clinical-stage biopharmaceutical company developing therapies for hard-to-treat cancers, which she founded in 2017 and has grown to more than 15 team members. Since the company's inception, she has raised over €100M in private financing, advanced two programs into mid-stage clinical development, and in-licensed an additional small molecule program. Before founding iOnctura, she led global oncology and immuno-oncology licensing and business development at Merck KGaA, and she holds a PhD in Medicinal Chemistry from the Institute of Cancer Research and an MBA from Henley Business School.

Co-Founder & CEO at iOnctura

Intro paths

→

In turn, Catherine can intro founders to iOnctura's investors below.

iOnctura's investors · 7

3B Future Health FundMonaco · $12M checks · since 2024InkefAmsterdam · since 2024Johnson & Johnson Innovation – JJDCNew Brunswick · since 2020M VenturesLos Angeles · $10.8M checks · since 2024SynconaLondon · since 2024VI PartnersAltendorf · $2.2M – $4.5M checks · since 2024XGEN VentureMilan

Co-founders at iOnctura

LVLars van der Veen
Lars van der VeenCo-Founder & CSO

Experience

  1. iOnctura SACEO & Foundercurrent2017 — presentGeneva Area, Switzerland
  2. iOnctura SAChief Executive Officercurrent2017 — present
  3. Merck SeronoHead of Oncology Licensing, Global Business Development2011 — 2017Geneva
  4. Merck SeronoDirector of Business Development2006 — 2011
  5. Antisoma PLCLicensing and Alliance Manager2004 — 2006
  6. The Institute of Cancer ResearchBusiness Development Manager2001 — 2004

Skills & more

Leadership5Strategy6Clinical Development24Biotechnology27Technology Transfer27Licensing18Pharmaceutical Industry21Pharmaceutics4Oncology30Regulatory Affairs3GCP1Global Business Development4
+12 moreDrug DiscoveryClinical ResearchBusiness DevelopmentMarketing StrategyMarket AccessBiopharmaceuticalsCROCommercializationDrug DevelopmentR&DClinical TrialsBusiness Strategy

From Catherine's professional profile.

Frequently asked questions

Who is Catherine Pickering?
Catherine Pickering is CEO and Co-Founder of iOnctura SA, a Swiss-Dutch clinical-stage biopharmaceutical company developing therapies for hard-to-treat cancers, which she founded in 2017 and has grown to more than 15 team members. Since the company's inception, she has raised over €100M in private financing, advanced two programs into mid-stage clinical development, and in-licensed an additional small molecule program. Before founding iOnctura, she led global oncology and immuno-oncology licensing and business development at Merck KGaA, and she holds a PhD in Medicinal Chemistry from the Institute of Cancer Research and an MBA from Henley Business School.
Where does Catherine Pickering work?
Catherine Pickering is Co-Founder & CEO of iOnctura.
What companies did Catherine Pickering found?
Catherine Pickering founded iOnctura.
Where did Catherine Pickering go to school?
Catherine Pickering studied at Henley Business School (Master of Business Administration (MBA)); The Institute of Cancer Research (Doctor of Philosophy (PhD), Medicinal and Pharmaceutical Chemistry).

Founder mafias

Same school

Shared employers